/Companies

SpotItEarly

Englewood, US · Founded 2024 · Delaware corporation · 1 known investors

Find your way into SpotItEarly

Sign up to see every warm intro you have to SpotItEarly

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the SpotItEarly team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

SpotitEarly develops an at-home, non-invasive cancer pre-screening test that analyzes volatile organic compounds in exhaled breath samples using trained canines combined with its LUCID AI platform of biosensors and data analysis. The multi-cancer early-detection product is offered to consumers via online subscription and has been validated in clinical trials with healthcare institutions in Israel and the U.S.

Founders & leadership

SpotItEarly was founded in 2024 by Ohad Sharon.

OSOhad Sharon
Ohad SharonCo-Founder & CSO (strategy)He has previous experience in digital health entrepreneurship and roles within Israel's intelligence community focused on innovation implementation.
RO
Roi OphirNamed on SEC filing
SM
Shlomi MadarNamed on SEC filing
SL
Shai LankryNamed on SEC filing
AR
Assaf RufNamed on SEC filing
JL
J. Leonard LichtenfeldNamed on SEC filing
AB
Ariel Ben DayanNamed on SEC filing
RE
Reef Einoch AmorPhD, Director of Chemical Analysis

Board

ALAlon Lifshitz
Alon LifshitzBoard directorCo-Founder and General Partner at Hanaco Venture Capital

Investors · 1

Reported raises · per SEC filings

Form D private placements

$10K disclosed across 1 round · 2025

▶$10KraisedAug 2025 · 1 investors · Biotechnology
Rule 506(c)
Officers, directors & promoters on the filing
  • Alon LifshitzDirector
  • Roi OphirDirector, Promoter
  • Shlomi MadarExecutive Officer, Director, Promoter
  • Shai LankryExecutive Officer, Director, Promoter
  • Assaf RufExecutive Officer
  • J. Leonard LichtenfeldExecutive Officer
  • Ariel Ben DayanDirector
Offering amount
$20M
Amount sold
$10K
Minimum investment
$100
First sale
Jul 2025
Incorporated
Corporation, Delaware, 2024
Federal exemptions
06c
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 3

Companies working in the same space as SpotItEarly.

Frequently asked questions

What does SpotItEarly do?
SpotitEarly develops an at-home, non-invasive cancer pre-screening test that analyzes volatile organic compounds in exhaled breath samples using trained canines combined with its LUCID AI platform of biosensors and data analysis. The multi-cancer early-detection product is offered to consumers via online subscription and has been validated in clinical trials with healthcare institutions in Israel and the U.S.
Who founded SpotItEarly?
SpotItEarly was founded by Ohad Sharon in 2024.
Who are SpotItEarly's investors?
SpotItEarly's investors include Hanaco Venture Capital.
How much funding has SpotItEarly raised?
SpotItEarly has disclosed $10K raised across 1 round.
Where is SpotItEarly headquartered?
SpotItEarly is headquartered in Englewood, US.